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LETTERS TO THE EDITOR
Coagulation abnormalities after Fontan
procedures
To the Editor:
We read with interest the article by Jahangiri and
associates in the June 1997 issue of the Journal (1997;113:
989-93). The concept of coagulation factor abnormalities
in children after Fontan procedures is not new and was
originally described by Cromme-Dijkhuis and associ-
ates1, 2 in 1990 and 1993. In two cross-sectional surveys of
children after Fontan procedures, Cromme-Dijkhuis and
colleagues described multiple coagulation factor abnor-
malities involving both procoagulant and anticoagulant
proteins. The authors noted that these abnormalities
tended to resolve as duration of follow-up lengthened.
However, closer examination of the Cromme-Dijkhuis
articles revealed that the reference ranges used by the
authors were not age-appropriate.3 The majority of the
plasma coagulation factor concentrations in these children
were in fact normal for age. The apparent normalization
with time reflected that with increasing age the children
“grew into” the adult reference ranges that had been
inappropriately applied previously. However, six of 19
patients in the Cromme-Dijkhuis series had higher throm-
bin-antithrombin (TAT) complexes than the age-appro-
priate normal ranges. Increased TAT complexes suggests
a prothrombotic condition, although the mechanism in
this instance remains unknown.
Unfortunately, Jahangiri and associates seem to have
made the same error as Cromme-Dijkhuis and colleagues.
In the Jahangiri article, the authors do not describe the
source of their reference ranges. The normal ranges
quoted are adult reference ranges and are not applicable
to the patient population in question. The lower limit of
normal for children 1 to 5 years of age is as low as 0.4
U/ml, in contrast to the 0.63 U/ml used by the authors.3 It
is likely that multiple age-related normal ranges need to
be applied to the study population. The actual serum
concentrations of the patients are not stated, and it is
likely that many of the children believed to have abnormal
values may be within the appropriate normal ranges. This
would drastically alter the results and conclusions of this
article.
There are many pitfalls to suggesting that patients have
coagulation abnormalities. Testing in the presence of
active thrombus may give false positive results. The meth-
ods used in collecting, processing, and assaying samples all
need rigorous control. The use of accurate normative data
is crucial to the definition of abnormal. The concept of
developmental hemostasis is well established, and pub-
lished normal ranges exist for premature and term infants,
as well as children of all ages.3-5
Whether children who have had the Fontan procedure
have a true prothrombotic condition, either congenital or
acquired, is uncertain. Prospective cohort studies per-
formed with appropriate techniques and compared with
age-appropriate normative data will answer the question.
The current study by Jahangiri and colleagues, because of
major methodologic flaws, does not.
Paul Monagle, MBBS
Maureen Andrew, MD
Hamilton Civic Hospital Research Centre
711 Concession St.
Hamilton, Ontario L9C 3G1, Canada
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Reply to the Editor:
We are aware of the excellent work of Dr. Andrew in
the field of coagulation in childhood. The normal ranges
quoted in the article were provided by the Thrombosis
Research Institute at the Royal Brompton Hospital. Drs.
Monagle and Andrew have quoted a normal range for
children between 1 and 5 years of age. In our study the
median age at the time of the Fontan repair was 6.2 years
and the median time from the Fontan repair to the time of
the study was 4.9 years. The normal range for children 1 to
5 years old, therefore, is not applicable to all the patients
in this group. Considering the normal range for 6- to
10-year-old and 11- to 16-year-old patients published by
Andrew and associates,1 the published results hold (Table
I). We have not noted any recovery of these coagulation
factors.
None of the patients in the study had a history of
thromboembolic episodes, and testing was not performed
in the presence of active thrombus. This eliminates the
chance for false positive results.
Marjan Jahangiri, FRCS
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